← Leaderboards
Zachary Miles
Alida Biosciences, Inc.
$3,085,724
Attributed
$3,659,116
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$3,659,116 · 3
By mechanism
R44$3,311,463 · 2
R43$347,653 · 1
Top collaborators
- Gudrun Stengel1 shared
Most similar at Alida Biosciences, Inc.
Same institution · by research overlap
- Gudrun Stengel$5,292,779
Others in their field
Other Rising Stars on “Malignant Neoplasms”
- David Annett · Information Management Services, Inc.$35,571,865
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jon White · Midwest Research Institute$17,594,074
- Carolina Porras · Fundacion Inciensa$10,814,023
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
Research focus
Malignant NeoplasmsPathway InteractionsEngineeringLibrariesMessenger RnaNovel DiagnosticsChemotherapy-Oncologic ProcedureDisease ProgressionEpitranscriptomeEpitranscriptomicsCommercializationDrug DevelopmentModificationBioinformaticsAccelerationBiologicalBiological SciencesAwardDetectionDiagnostic BiomarkerBar CodesCodeCellsProteins
Grant awards (4)
Pseudouridine detection with single-base resolution in a multiplexed epitranscriptomics assay$1,146,785
R44 · FY2025 · GM · contact PI
Engineered RNA Modification Recognition$1,082,339
R44 · FY2025 · GM · contact PI
Engineered RNA Modification Recognition$1,082,339
R44 · FY2024 · GM · contact PI
Engineered RNA Modification Recognition$347,653
R43 · FY2023 · HG · contact PI